TELA Bio, Inc. (TELA)
Healthcare
- Fundamental
- 1
- Sentiment
- 1
- Technical
- 1
Do Nothing: fundamentalScore 1 and qualitativeScore 1 are below the required floor of 3, and liquidity is far below both strategy minimums.
Company overview
TELA Bio, Inc. is a medical technology company specializing in soft-tissue reconstruction solutions. Its product portfolio includes OviTex Reinforced Tissue Matrix for hernia repair and abdominal wall reconstruction, and OviTex PRS for plastic and reconstructive surgery. The company operates primarily in the United States through a direct sales force.
Fundamental
very weakTELA Bio faces significant going-concern and listing compliance risks despite historical revenue growth.
TELA shows strong multi-year top-line growth and resilient gross margins, but the latest SEC filing contains an explicit substantial-doubt going-concern disclosure tied to ongoing losses, cash burn, and covenant sensitivity under its credit agreement. Cash has declined materially year-to-date, equity has turned negative, and Nasdaq minimum bid-price compliance is a near-term risk. Despite a seemingly low EV/Sales multiple, the fundamental setup is dominated by solvency and financing/listing uncertainty rather than operating momentum.
Sentiment
very weakMarket sentiment is negative, driven by recent earnings misses and guidance withdrawal.
Last ~14d media tone is negative (polarity_score ≈ -0.24) around the Q2 loss/revenue miss and guidance withdrawal, with additional post-print price-target cuts. Baseline sentiment delta is indeterminate this run due to a baseline-window timeout, and a severe red-flag cap applies due to an explicit going-concern/substantial-doubt disclosure in the latest quarterly filing (per upstream SEC-based pipeline stage).
Technical
very weakThe stock is in a bearish trend with low liquidity and weak momentum indicators.
Technical score 1/5: price is below every key moving average and daily VWAP, MACD is negative and below its signal, and ADX 38.90 confirms the active trend is still down; oversold Williams %R alone is not a bullish setup.
You’re looking at 2026-08-19 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.